We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMI icon
1176
Cummins
CMI
$87.4B
– –
-1,036
Closed -$339K
CMPOW
1177
DELISTED
CompoSecure Inc Warrant
CMPOW
– –
-16,560
Closed -$104K
CMPS
1178
Compass Pathways
CMPS
$1.78B
– –
-66,975
Closed -$188K
CNM icon
1179
Core & Main
CNM
$8.67B
– –
-5,733
Closed -$346K
CPT icon
1180
Camden Property Trust
CPT
$11B
– –
-3,127
Closed -$352K
CRGX
1181
DELISTED
CARGO Therapeutics
CRGX
– –
-22,141
Closed -$91.2K
CRNX icon
1182
Crinetics Pharmaceuticals
CRNX
$8.93B
– –
-18,328
Closed -$527K
CRS icon
1183
Carpenter Technology
CRS
$27.8B
– –
-1,725
Closed -$477K
CRUS icon
1184
Cirrus Logic
CRUS
$6.11B
– –
-3,160
Closed -$329K
CSCO icon
1185
Cisco
CSCO
$483B
– –
-11,100
Closed -$770K
CVLT icon
1186
Commault Systems
CVLT
$5.78B
– –
-1,443
Closed -$252K
CWAN
1187
DELISTED
Clearwater Analytics
CWAN
– –
-12,017
Closed -$264K
CXDO icon
1188
Crexendo
CXDO
$209M
– –
-15,232
Closed -$92.5K
DBRG icon
1189
DigitalBridge
DBRG
$2.95B
– –
-11,060
Closed -$114K
DD icon
1190
DuPont de Nemours
DD
$19.1B
– –
-2,861
Closed -$246K
DGRO icon
1191
iShares Core Dividend Growth ETF
DGRO
$43.7B
– –
-3,546
Closed -$227K
DHR icon
1192
Danaher
DHR
$147B
– –
-1,055
Closed -$208K
DLB icon
1193
Dolby
DLB
$5.82B
– –
-9,296
Closed -$690K
DNB
1194
DELISTED
Dun & Bradstreet
DNB
– –
-520,291
Closed -$4.73M
DNLI icon
1195
Denali Therapeutics
DNLI
$4B
– –
-15,940
Closed -$223K
DNUT icon
1196
Krispy Kreme
DNUT
$542M
– –
-16,211
Closed -$47.2K
DOC icon
1197
Healthpeak Properties
DOC
$14.4B
– –
-84,092
Closed -$1.47M
DOCS icon
1198
Doximity
DOCS
$4.57B
– –
-4,436
Closed -$272K
DOX icon
1199
Amdocs
DOX
$6.22B
– –
-4,314
Closed -$394K
DRI icon
1200
Darden Restaurants
DRI
$24.9B
– –
-1,433
Closed -$312K
46 47
48
49 50

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.